Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. - Test2 - elhamkhani - TriplyDB

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

http://www.wikidata.org/entity/Q34048276

about

Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas MicroRNAs in NF-kappaB signaling Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia Cap-Independent Translation in Hematological Malignancies microRNA regulation of peritoneal cavity homeostasis in peritoneal dialysis The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)Epigenomics of leukemia: from mechanisms to therapeutic applications MicroRNAs: new regulators of Toll-like receptor signalling pathways Epigenetics advancing personalized nanomedicine in cancer therapy MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tune The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells The prognostic and functional role of microRNAs in acute myeloid leukemia Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs The Role of the Ubiquitously Expressed Transcription Factor Sp1 in Tissue-specific Transcriptional Regulation and in Disease The microRNA-29 family in cartilage homeostasis and osteoarthritis MicroRNA-29a inhibited epididymal epithelial cell proliferation by targeting nuclear autoantigenic sperm protein (NASP)MicroRNA regulation of innate immune responses in epithelial cells Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells.Cell-specific expression of aquaporin-5 (Aqp5) in alveolar epithelium is directed by GATA6/Sp1 via histone acetylation The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis.Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction.ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer.miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB.Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis.Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia.The role of microRNAs in acute myeloid leukemia.Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases.Pathogenic microRNA's in myeloid malignancies.Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice.MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives.Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation.Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29.Function and mechanism of tumor suppressor gene LRRC4/NGL-2.NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival.MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib.MicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia.

P2860

Q24301269-BCF27DBD-2616-4E9B-935F-C9980D4A02C1 Q24630097-3740CE1D-826A-4CD8-AA1C-CECB1F0F014D Q24633394-C2801D31-DE4B-4C83-A1F1-A42F9F11BB08 Q26770568-A6F66083-6AE7-4AD6-A6EF-4A6E7C3C460A Q26779972-CC12CE4E-E34C-4860-B6FA-BC0DBD0DB764 Q26799398-9B0BEEA1-8E08-4707-9663-69BE660B7128 Q26823403-D7F2D510-565A-42AF-AA6E-58ED459BC138 Q27010055-DCA47BF8-BCFB-4215-994D-722974D4EFFE Q27010637-3E3092C2-74BE-4579-9F32-A787938F5051 Q27013740-160938C3-AF95-48FD-B70B-11988409A6AE Q27313466-E28DBFB5-3C42-4164-A811-E00A0B467255 Q27693865-611A6662-CFD9-47A8-8DB9-415243C3ADC8 Q28071427-683BF101-EAE3-4194-8CD2-1AB1350B7F39 Q28076855-2F8DFC0B-5676-4159-8381-1CE917049DC2 Q28115325-FCCFC144-4316-460B-BE1D-79E9500E52AF Q28566117-0BB20026-7F3B-4A00-9F01-6FCF7AF8360C Q33577518-27361F0B-D236-415D-9D20-34F0B795B785 Q33798412-AB998BB8-A507-43F7-93DD-0C291419CD2B Q33799346-F53253CE-4B50-4964-8923-C0EBA3CBDA47 Q33842055-AB9BE262-03C7-48AB-A7EC-BF0EBEB43120 Q33859252-30FC85E3-C268-45DE-898D-30AC29C2AB41 Q33974555-C66A2F1D-D96F-4113-9515-3AFD131ECFAE Q34168267-5581B290-1B41-4B61-92A3-997BFF3157D4 Q34180373-09D7B9EA-B7C2-400A-A078-72917498AF4A Q34193684-88BDB3CA-2295-45B7-A76E-8157398DC4B2 Q34221688-883BDE84-A831-4A38-AC40-962B268F2F6E Q34309928-BE90E943-D3AE-473E-90D1-BA02843C5D36 Q34389746-0A081BD9-8633-4D32-B620-28E53B111402 Q34458438-915CE5AD-4C61-4D23-AFC5-BFC83C748B06 Q34541057-E75E866A-5036-4AAD-AFDC-287537708A9C Q34542559-D6C8269F-D8C4-43A6-96E7-48EF92E8647B Q34599354-FE7AFC7A-D3EA-48F2-BC07-7881253C5941 Q34875675-255E9239-F2D5-41C1-9A7A-8B0F8502BA56 Q34979339-300F48E3-D1DD-4CD2-9681-2E802873B26C Q35029942-388D4D57-D7E0-4794-9865-C66800F18871 Q35065212-C1EF620D-0D78-46A2-8091-70D245F087ED Q35147345-D59BADCD-BC44-4C16-AA75-B1AEFCAA6FB5 Q35167587-79F38664-E7A3-4863-9272-CE661EFD02FF Q35178969-365D655E-7BFB-4239-BA67-D3BD78380C56 Q35190147-C6641AD4-B7FA-4CD4-AA11-8C1C6D4B96E1

P2860

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

http://www.wikidata.org/entity/Q34048276

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

@ast

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

@en

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

@nl

type

label

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

@ast

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

@en

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

@nl

prefLabel

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

@ast

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

@en

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

@nl

P1433

Q34048276-DC1AF95A-A4BD-4123-A31D-08AF009BBBEC

P1476

Q34048276-400F6062-EC87-4378-AF61-C7D517B85003

P2093

Q34048276-0E8CB189-56EB-4BFF-A96B-2030087ADB27

Q34048276-3DEEF0BA-9E56-4B8D-9B7D-CB31FC6CAF57

Q34048276-3E06C9D5-6DB5-4397-B00B-35C620267E26

Q34048276-53F30FDE-20F2-4BE8-A2B7-78990893D197

Q34048276-57820172-FAE9-4668-B8B3-1160DB1D3B96

Q34048276-59B78C9D-B569-405A-9247-30E74923F458

Q34048276-65A6CFDF-8B81-4F2F-B947-94CD0D1A723C

Q34048276-73803E40-DD98-472A-BF79-E15D613F4541

Q34048276-7E951991-F439-4DAA-95A7-57C2F9D6B57A

Q34048276-8D9A6CB8-4489-45C5-A248-F67F5BA823C7

P2860

Q34048276-12F5C0E3-6EFA-4005-BD3B-E5B0CFF0BB08

Q34048276-17370877-9962-4C9E-BAB5-86411228B879

Q34048276-23081CC9-FE17-41F4-8A80-8ADCC54918C5

Q34048276-2D302978-0012-4E5C-8677-BB33D954A0B5

Q34048276-325CFF28-53AF-4A3C-88BA-0E62DAE5637E

Q34048276-44783209-B406-495D-8802-BEB3AEEA73B4

Q34048276-462A18B6-D295-4352-9407-1501767BCA06

Q34048276-4903088E-8B57-436F-9FE8-AF9032ABB04F

Q34048276-4A267A5C-DFD1-4FBD-80A2-AB50D3CC4E5C

Q34048276-4A3D7A49-7AC3-4C34-80BD-F73685D7149D

P304

Q34048276-86CE9A11-105F-410C-9F4B-D14E04F58B57

P31

Q34048276-4D779472-7265-4A9F-ADD2-5E92931644AD

P356

Q34048276-BA201ABB-1746-43AF-88B0-42F81D1E3F0A

P433

Q34048276-A50F9EF9-C1D2-482A-8DB9-A338DB453CBD

P478

Q34048276-49966F99-B4CB-4E60-BD2B-2E8F36625199

P50

Q34048276-1A046145-56CB-4191-A785-350E328A3407

Q34048276-4C0969EE-861F-4065-97BE-2E49D6CEF837

Q34048276-90A88F0F-7818-4180-A018-32FF54885312

Q34048276-E3E13947-2736-41EE-B0B2-4FBD06B61749

Q34048276-F22A53DB-9449-4079-939F-A0B9AB39CE8B

P577

Q34048276-C8664764-6A98-48D0-A2AF-5316FA86D926

P5875

Q34048276-4A3F74BE-1C2A-4553-8C20-3897ACD1125E

P698

Q34048276-20D03B88-5792-4DCB-A3C0-D54D8D5BA8FD

P921

Q34048276-D723E16A-8756-43DE-990D-B2B503F2D5C0

P932

Q34048276-DED260A3-62B5-4F9A-89DE-D1C7935C2B5B

P356

J.CCR.2010.03.008

P1433

P1476

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

@en

P2093

Anjali Mishra

http://www.w3.org/2001/XMLSchema#string

Anna M Eiring

http://www.w3.org/2001/XMLSchema#string

Chenglong Li

http://www.w3.org/2001/XMLSchema#string

Christopher J Hickey

http://www.w3.org/2001/XMLSchema#string

Danilo Perrotti

http://www.w3.org/2001/XMLSchema#string

Heiko Becker

http://www.w3.org/2001/XMLSchema#string

Jianhua Yu

http://www.w3.org/2001/XMLSchema#string

Jiuxia Pang

http://www.w3.org/2001/XMLSchema#string

Kenneth K Chan

http://www.w3.org/2001/XMLSchema#string

Lai-Chu Wu

http://www.w3.org/2001/XMLSchema#string

P2860

SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.

Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand

Widespread microRNA repression by Myc contributes to tumorigenesis

MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals

KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients

Cell signaling by receptor tyrosine kinases

Summaries of Affymetrix GeneChip probe level data

A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

A comparison of normalization techniques for microRNA microarray data.

P304

333-347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2010.03.008

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Clara D. Bloomfield

Carlo Maria Croce

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43130557

http://www.w3.org/2001/XMLSchema#string

P698

20385359

http://www.w3.org/2001/XMLSchema#string

P921

P932

2917066

http://www.w3.org/2001/XMLSchema#string